Protein detail

CD2

T-cell surface antigen CD2 (Erythrocyte receptor) (LFA-2) (LFA-3 receptor) (Rosette receptor) (T-cell surface antigen T11/Leu-5) (CD antigen CD2)

Entry name
CD2
UniProt ID
EVMP score
0.50
Frequency
1
Transmembrane count
1
Protein classification
CD markersFDA approved drug targetsPredicted intracellular proteinsPredicted membrane proteins
EVMP score: annotation confidence score.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
Basic Information
Protein Names
T-cell surface antigen CD2 (Erythrocyte receptor) (LFA-2) (LFA-3 receptor) (Rosette receptor) (T-cell surface antigen T11/Leu-5) (CD antigen CD2)
Protein Class
CD markersFDA approved drug targetsPredicted intracellular proteinsPredicted membrane proteins
Protein Function
  • CD markers
  • Predicted intracellular proteins
  • FDA approved drug targets:Biotech drugs
Transmembrane
210..235; Helical
Transmembrane Count
1
Entrez Gene Symbol
Gene Synonym
SRBC
Gene Description
CD2 molecule
Chromosome
1
Position
116754430-116769229
Frequency
1
EVMP Score
0.50
Fluorescence & Localization
Tissue Specificskin 1Cell SpecificDistal convoluted tubule cellsSingle-Nuclei Brain Specificchoroid plexus epithelial cellBlood Cell SpecificT-reg
Function & Pathway
Relations & Evidence

Enzyme-Mediated Modification

0 records.

Ligand-Receptor Signaling

50 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
cell_surfacecell_surfaceBaccin2019NoNoNoYesNo
cell_surfacecell_surfaceOmniPathNoNoNoYesNo
receptorreceptorCellinkerNoYesNoYesNo
receptorreceptorscConnectNoYesNoYesNo
receptorreceptorconnectomeDB2020NoYesNoYesNo
receptorreceptorCellCellInteractionsNoYesNoYesNo
transmembranetransmembrane_predictedPhobiusNoNoNoYesNo
transmembrane_phobiustransmembrane_predictedAlmen2009NoNoNoYesNo
transmembrane_sosuitransmembrane_predictedAlmen2009NoNoNoYesNo
transmembrane_tmhmmtransmembrane_predictedAlmen2009NoNoNoYesNo
Page 5 of 5Previous

Regulatory Interaction Network

0 records.

Protein Complex Composition

130 records.

Component NameComponent Gene SymbolsComponent UniProt IDStoichiometryDatabaseDatabase IDsReferences
Ikaros complexCHD4CHD5HDAC1HDAC2IKZF1IKZF2IKZF3RBBP4SMARCA2SMARCA4SMARCC1SMARCC2SMARCD1SMARCD2SMARCD3P51531P51532Q09028Q13422Q13547Q14839Q6STE5Q8TAQ2Q8TDI0Q92769Q92922Q92925Q96GM5Q9UKS7Q9UKT91:1:1:1:1:1:1:1:1:1:1:1:1:1:1CompleatCompleat:HC84510204490
LARC complex (LCR-associated remodeling complex)ACTBACTL6AARID1ACHD4DPF2GATAD2BHDAC1HDAC2HNRNPCMBD2MBD3MTA2RBBP4SMARCA4SMARCB1SMARCC1SMARCC2SMARCD2SMARCE1O14497O94776O95983O96019P07910P51532P60709Q09028Q12824Q13547Q14839Q8TAQ2Q8WXI9Q92769Q92785Q92922Q92925Q969G3Q9UBB51:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1CompleatCORUMCORUM:778Compleat:HC11216217013
MDC1-MRN-ATM-FANCD2 complexATMFANCD2MDC1MRE11NBNRAD50O60934P49959Q13315Q14676Q92878Q9BXW91:1:1:1:1:1CompleatCORUMCompleat:HC2826CORUM:221712607005
Muscle cell-specific SWI/SNF ARID1A variantACTBACTL6AARID1ADPF3SMARCA2SMARCB1SMARCC1SMARCC2SMARCD1SMARCD2SMARCD3SMARCE1O14497O96019P51531P60709Q12824Q6STE5Q8TAQ2Q92784Q92922Q92925Q969G3Q96GM51:1:1:1:1:1:1:1:1:1:1:1SIGNORComplexPortalPDB:5gjkSIGNOR:SIGNOR-C481intact:EBI-16362106188096731179055898435042840864798453651262022614755292108844061107398823644491
Muscle cell-specific SWI/SNF ARID1B variantACTBACTL6AARID1BDPF3SMARCA2SMARCB1SMARCC1SMARCC2SMARCD1SMARCD2SMARCD3SMARCE1O96019P51531P60709Q12824Q6STE5Q8NFD5Q8TAQ2Q92784Q92922Q92925Q969G3Q96GM51:1:1:1:1:1:1:1:1:1:1:1SIGNORComplexPortalintact:EBI-16365908PDB:5gjkSIGNOR:SIGNOR-C48218809673117905589843504284086479845365126202262869582214755292108844061107398823644491
Muscle cell-specific SWI/SNF ATP-dependent chromatin remodeling complexACTL6A-ARID1A-SMARCA4 variantACTBACTL6AARID1ADPF3SMARCA4SMARCB1SMARCC1SMARCC2SMARCD1SMARCD2SMARCD3SMARCE1O14497O96019P51532P60709Q12824Q6STE5Q8TAQ2Q92784Q92922Q92925Q969G3Q96GM51:1:1:1:1:1:1:1:1:1:1:1ComplexPortalPDB:5gjkintact:EBI-16365821188096731179055898435042840864798453651262022614755292108844061107398823644491
Muscle cell-specific SWI/SNF ATP-dependent chromatin remodeling complexACTL6A-ARID1B-SMARCA4 variantACTBACTL6AARID1BDPF3SMARCA4SMARCB1SMARCC1SMARCC2SMARCD1SMARCD2SMARCD3SMARCE1O96019P51532P60709Q12824Q6STE5Q8NFD5Q8TAQ2Q92784Q92922Q92925Q969G3Q96GM51:1:1:1:1:1:1:1:1:1:1:1ComplexPortalintact:EBI-16365985PDB:5gjk18809673117905589843504284086479845365126202262869582214755292108844061107398823644491
Muscle cell-specific SWI/SNF ATP-dependent chromatin remodeling complexACTL6B-ARID1A-SMARCA2 variantACTBACTL6BARID1ADPF3SMARCA2SMARCB1SMARCC1SMARCC2SMARCD1SMARCD2SMARCD3SMARCE1O14497O94805P51531P60709Q12824Q6STE5Q8TAQ2Q92784Q92922Q92925Q969G3Q96GM51:1:1:1:1:1:1:1:1:1:1:1ComplexPortalintact:EBI-16366061PDB:5gjk188096731179055898435042840864798453651262022614755292108844061107398823644491
Muscle cell-specific SWI/SNF ATP-dependent chromatin remodeling complexACTL6B-ARID1B-SMARCA2 variantACTBACTL6BARID1BDPF3SMARCA2SMARCB1SMARCC1SMARCC2SMARCD1SMARCD2SMARCD3SMARCE1O94805P51531P60709Q12824Q6STE5Q8NFD5Q8TAQ2Q92784Q92922Q92925Q969G3Q96GM51:1:1:1:1:1:1:1:1:1:1:1ComplexPortalintact:EBI-16366251PDB:5gjk18809673117905589843504284086479845365126202262869582214755292108844061107398823644491
Muscle cell-specific SWI/SNF ATP-dependent chromatin remodeling complexACTL6B-ARID1B-SMARCA4 variantACTBACTL6BARID1BDPF3SMARCA4SMARCB1SMARCC1SMARCC2SMARCD1SMARCD2SMARCD3SMARCE1O94805P51532P60709Q12824Q6STE5Q8NFD5Q8TAQ2Q92784Q92922Q92925Q969G3Q96GM51:1:1:1:1:1:1:1:1:1:1:1ComplexPortalintact:EBI-16366324PDB:5gjk18809673117905589843504284086479845365126202262869582214755292108844061107398823644491
Page 3 of 13PreviousNext

Isolation & Detection Technology

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Differential UltracentrifugationMass spectrometry123161513
Sequence, Structure & Domains

Sequences

Length
351
Mass
39,448
Sequence
MSFPCKFVASFLLIFNVSSKGAVSKEITNALETWGALGQDINLDIPSFQMSDDIDDIKWEKTSDKKKIAQFRKEKETFKEKDTYKLFKNGTLKIKHLKTDDQDIYKVSIYDTKGKNVLEKIFDLKIQERVSKPKISWTCINTTLTCEVMNGTDPELNLYQDGKHLKLSQRVITHKWTTSLSAKFKCTAGNKVSKESSVEPVSCPEKGLDIYLIIGICGGGSLLMVFVALLVFYITKRKKQRSRRNDEELETRAHRVATEERGRKPHQIPASTPQNPATSQHPPPPPGHRSQAPSHRPPPPGHRVQHQPQKRPPAPSGTQVHQQKGPPLPRPRVQPKPPHGAAENSLSPSSN

3D Structural Models

Turn
88..90; 139..142
Helix
62..64; 73..75; 99..101
Beta Strand
31..36; 41..43; 52..61; 67..71; 77..80; 84..86; 92..94; 103..111; 116..127; 134..138; 143..147; 155..162; 164..170; 172..175; 180..189; 194..203
3D Structure
NMR spectroscopy (3); X-ray crystallography (4)

Domain & Motif Annotations

Compositional Bias
243..262; Basic and acidic residues; 269..280; Polar residues; 326..338; Pro residues
Domain (FT)
25..128; Ig-like V-type; 129..209; Ig-like C2-type
Region
61..75; CD58 binding region 1; 106..120; CD58 binding region 2; 237..351; Disordered
Clinical Relevance
Disease Involvement
FDA approved drug targets
Related Diseases
Biomarker
Phase 2; Discontinued in Phase 2
Drug Targets
FDA approved drug targets
Interaction Protein
ENSG00000140368ENSG00000147010ENSG00000169217ENSG00000198087
Interaction Count
4
Interaction Dataset
intact_biogrid